C - Chemistry – Metallurgy – 07 – K
Patent
C - Chemistry, Metallurgy
07
K
C07K 16/22 (2006.01) A61K 39/395 (2006.01) A61P 35/00 (2006.01) C12N 15/02 (2006.01) C12P 21/08 (2006.01)
Patent
CA 2654572
There has been a demand for a pharmaceutical for the treatment of a disease characterized by the increase in an HB-EGF. Disclosed is a monoclonal antibody capable of binding to an HB-EGF binding to a cell membrane, a membrane-anchored HB-EGF or a secreted HB-EGF or a fragment of the antibody.
Il existe un besoin de produits pharmaceutiques permettant le traitement d'une maladie caractérisée par l'accroissement de HB-EGF. L'invention concerne donc un anticorps monoclonal, ou un fragment dudit anticorps, capable de se lier à un HB-EGF de liaison à une membrane cellulaire, à un HB-EGF fixé à une membrane ou à un HB-EGF sécrété.
Ando Hiroshi
Furuya Akiko
Iwamoto Ryo
Masuda Kazuhiro
Mekada Eisuke
Goudreau Gage Dubuc
Kyowa Hakko Kirin Co. Ltd.
LandOfFree
Monoclonal antibody capable of binding to heparin-binding... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Monoclonal antibody capable of binding to heparin-binding..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Monoclonal antibody capable of binding to heparin-binding... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1939320